Comunicati Stampa
Ambiente

STEERLife Redefines Potent Drug Development with Clean, Green, Continuous Processing

At the core of this advancement is STEERLife's proprietary solvent-free melt fusion technology, a continuous processing system that eliminates the need for harmful organic solvents. Designed to precisely handle high-potency and hard-to-develop molecules, this platform significantly enhances formulation efficiency, safety, and scalability. At the core of this advancement is  STEER Life 's proprietary solvent-free melt fusion technology, a continuous processing system that eliminates the need...
India, (informazione.news - comunicati stampa - ambiente)

At the core of this advancement is  , a continuous processing system that eliminates the need for harmful organic solvents. Designed to precisely handle high-potency and hard-to-develop molecules, this platform significantly enhances formulation efficiency, safety, and scalability.

As a next-generation Contract Research, Development & Manufacturing Organization (CRDMO), STEER  provides comprehensive development capabilities for complex and potent drugs - including NCEs, hormone therapies, orphan drugs, complex generics (ANDAs) and 505(b)(2) products, assisting global pharma in overcoming development and manufacturing challenges through process-driven innovation.

"Potent drug development demands more than just compliance; it requires control, care, and innovation,"  . "Our continuous, solvent-free platform brings all of that together - enabling faster, cleaner and more scalable development for the world's most demanding therapies."

STEER  has already initiated the development of several key drug products set for market release from 2026 onwards. These include generic versions of   reflecting the company's ability to take on complex, high-barrier drug programs with confidence.

Working in tandem with partner facilities, STEER  is strategically positioned to serve leading pharmaceutical markets across the 

As a company that pioneered the shift from batch to seamless continuous processing in India , STEER continues to lead the evolution of pharmaceutical manufacturing - empowering clients worldwide to shorten development timelines, raise quality benchmarks and unlock next-gen drug delivery.

, a division of STEER World, is a pioneering life sciences company transforming how pharmaceuticals are developed, manufactured, and consumed. Leveraging cutting-edge continuous processing and proprietary clean & green technologies, STEER  enables faster, greener and more efficient drug development. The company offers a complete spectrum of services to global partners: ranging from formulation and analytical development to technology transfer, regulatory support and commercial-scale manufacturing.

Logo: https://mma.prnewswire.com/media/2687390/STEERLife_Logo.jpg

 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/steerlife-redefines-potent-drug-development-with-clean-green-continuous-processing-302456531.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili